PedAM
Pediatric Disease Annotations & Medicines
| Disease | myelodysplastic syndrome |
| Symptom | C0040034|thrombocytopenia |
| Sentences | 11 |
| PubMedID- 22129476 | thrombocytopenia is common in patients with myelodysplastic syndromes (mds) and immune destruction of platelets could be an important factor for its occurrence. |
| PubMedID- 20620439 | thrombocytopenia in patients with myelodysplastic syndromes. |
| PubMedID- 22967412 | Objective: to investigate the prognostic value of thrombocytopenia in patients with primary myelodysplastic syndromes (mds). |
| PubMedID- 21575929 | Significance of thrombocytopenia in myelodysplastic syndromes: associations and prognostic implications. |
| PubMedID- 25632241 | Giagounidis et al reported the results of a comparison of romiplostim and placebo for treatment of thrombocytopenia in patients with myelodysplastic syndrome.72 despite promising results showing increased platelet counts, decreased number of bleeding events, and decreased platelet transfusions in the romiplostim arm, the study was discontinued early due to concerns of excess blasts and the rate of aml. |
| PubMedID- 23682236 | However, thrombocytopenia, due to myelodysplastic syndrome, likely resulting from the prior chemotherapy described above, was evident and his platelet count was ~50 × 109/l. |
| PubMedID- 23403320 | Plasma thrombopoietin levels were measured in 120 patients who had myelodysplastic syndrome with thrombocytopenia (< 100 x 10(9)/l) to determine any correlation to markers associated with immune pathophysiology and outcome. |
| PubMedID- 23190430 | Background: lenalidomide treatment in myelodysplastic syndrome (mds) may lead to thrombocytopenia and dose reductions/delays. |
| PubMedID- 25659186 | thrombocytopenia in patients with myelodysplastic syndromes (mds) is a frequent cause of haemorrhage-related morbidity and mortality, and is associated with increased risk of leukaemic transformation and reduced overall survival. |
| PubMedID- 24706489 | Background: thrombocytopenia in patients with myelodysplastic syndrome (mds) is associated with shortened survival and an increased risk of evolution to acute myeloid leukemia (aml). |
| PubMedID- 25368823 | A case of refractory thrombocytopenia with 5q deletion: myelodysplastic syndrome mimicking idiopathic thrombocytopenic purpura. |
Page: 1